Prevalence and clinical and histological manifestation of hepatitis g/gbv-c infections in patients with elevated aminotransferases of unknown etiology

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 276-283

  Sarrazin, Christoph ^a   Herrmann, Günter ^b   Kurt Roth, W ^c   Lee, Jung Hun ^a   Marx, Sylvia ^c   Zeuzem, Stefan ^a  

^a Medizinische Klinik II   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

GB virus C; Hepatitis G virus; Liver histology; Non A E hepatitis; Reverse transcriptionpolymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

EID: 0030749980     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80172-9     Document Type: Article

References (23)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA. 92:1995;3401-3405.
2. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol. 46:1995;81-90.
3. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1:1995;564-569.
4. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non A-E hepatitis. J Med Virol. 48:1995;60-67.
5. Pilot-Matias A, Muerhoff AS, Simons JN, Leary TP, Buijk SL, Chalmers ML, et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B and GBV-C. J Med Virol. 48:1996;329-338.
6. Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
7. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
8. Hadziyannais S, Wages J, Kim JP, Karayiannis P, Hess G, Piatek M, et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. Annual Meeting of the European Association for the Study of the Liver, Copenhagen J Hepatol. 23:August 20-23, 1995;78A. (Suppl 1).
9. Nübling CM, Löwer J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin. Lancet. 347:1996;68.
10. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology. 19:1994;1337-1341.
11. Yokosuka O, Omata M, Hosoda K, Tada M, Ehata T, Ohto M. Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. Gastroenterology. 100:1991;175-181.
12. Rüster B, Zeuzem S, Roth WK. Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. Anal Biochem. 224:1995;597-600.
13. Kwok S, Higushi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
14. Van de Peer Y, De Wachter R. Treecon for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci. 10:1994;569-570.
15. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 16:1980;111-120.
16. Saitou N, Nei M. The neighbour-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 4:1987;406-425.
17. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 39:1985;783-791.
18. Muerhoff AS, Simons JN, Leary TP, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Identification of conserved sequences 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. IX International Symposium on Viral Hepatitis and Liver Disease. April 21-25, 1996;. Abstr. 217, 257.
19. Mukaide M, Mizokami M, Orito E, Ohba K, Nakano T, Ueda R, et al. There are three subtypes of GB virus-C/hepatitis G virus (HGV): geographic distribution and HGV RNA levels. Hepatology. 24:1996;287A. (Suppl 1).
20. Roth WK, Waschk D, Marx S, Tschauder S, Zeusem S, Bialeck H, et al. Prevalence of GB virus-C/hepatitis G virus in blood donations and transmission to recipients. Transfusion. 38:1997;. (in press).
21. Alter HJ, Nakatsuij Y, Shih JW-K, Melpolder J, Kiyosawa K, Wages J, et al. Transfusion-associated hepatitis G virus infection. IX International Symposium on Viral Hepatitis and Liver Disease. April 21-25, 1996;. Abstr. 120, 34.
22. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
23. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Böker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 348:1996;1626-1629.